A review of recent data regarding frequency of allergic reactions has shown similar rates of anaphylaxis to COVID vaccines as to other vaccines.
Following the rollout of COVID vaccines at the start of 2021, initial reports emphasized a high risk of allergic reactions, however, data has shown that this may have been caused by over-classifications and misinterpretations of anxiety.
The review concluded that “COVID-19 vaccines and mRNA vaccine technology are overwhelmingly safe and well-tolerated by most patients”. In the rare cases where a patient shows signs and symptoms of anaphylaxis they may be candidates for alternatives to vaccination including monoclonal antibodies.
The review also outlined how healthcare professionals can help concerned patients and how to differentiate between a true anaphylactic reaction, a mild allergic reaction, and subjective symptoms possibly attributable to anxiety.
Read the full article here.
Provide your email address to receive our printable guide outlining emergency symptoms and actions.
Additionally, enjoy our monthly Allergy Outlook email, delivering the latest news, updates, and resources directly to your inbox.